Healthcare innovation has traditionally been evaluated through the lenses of scientific novelty, technological sophistication, and commercial scalability. Yet an increasingly decisive factor lies beneath these visible attributes: research integrity. In a regulatory environment defined by scrutiny, transparency, and patient safety, the credibility of the underlying research is no longer merely an ethical consideration. It is